The FDA’s Relaxed Regulations During the COVID-19 Pandemic and New Business Opportunities
Since the COVID-19 outbreak in the United States, we see news every day about shortages of personal protective equipment (PPE). In the past three months the FDA has relaxed many of its regulations and policies, with the intention of mitigating these shortages. For example, the FDA relaxed both pre-marketing and post-marketing requirements and issued Emergency Use Authorizations for devices and equipment that are within and outside its jurisdiction. These temporary rules apply to both domestic and international companies and create new business opportunities in this challenging time. In this webinar, Wilson Elser of counsels Jianlin Song (San Francisco) and Tawana Johnson (Atlanta) will talk about the FDA’s temporary policies pertaining to medical devices, drugs, clinical tests and personal protective equipment, and how we can help our clients take advantage of these relaxed rules for the time being and in the long run.